Showing results (2041-2050 of 4,519) with videos related to

Sort By:
Pageof 452
Advances in Therapy|April 6, 2021
First-Line Atezolizumab for Metastatic NSCLC with High PD-L1 Expression: A United States-Based Cost-Effectiveness AnalysisYe Peng, Xiaohui Zeng, Liubao Peng, et al.
Advances in Therapy|April 7, 2021
Sensitivity, Specificity and Accuracy of a Novel EEG-Based Objective Test, the Cognalyzer®, in Detecting Cannabis Psychoactive EffectsAlison C McDonald, Israel Gasperin Haaz, Weikai Qi, et al.
Advances in Therapy|April 6, 2021
Comparative Efficacy of Cabozantinib and Ramucirumab After Sorafenib for Patients with Hepatocellular Carcinoma and Alpha-fetoprotein ≥ 400 ng/mL: A Matching-Adjusted Indirect ComparisonJörg Trojan, Patrick Mollon, Bruno Daniele, et al.
Advances in Therapy|April 9, 2021
Capsule and Sprinkle Formulations of Lubiprostone Are Not Biologically Similar in Patients with Functional ConstipationAtoya Adams, Charles Barish, Angel Chen, et al.
Advances in Therapy|April 9, 2021
Predictors of 30-Day Unplanned Readmission After Carotid Artery Stenting Using Artificial IntelligenceAmod Amritphale, Ranojoy Chatterjee, Suvo Chatterjee, et al.
Advances in Therapy|August 26, 2020
Rheumatological Manifestations in HIV-Positive Patients: A Single-Center StudyRenu Saigal, Avik Chakraborty, Ram Narayan Yadav, et al.
Advances in Therapy|April 19, 2021
A Clinical and Budgetary Impact Analysis of Introducing Sugammadex for Routine Reversal of Neuromuscular Blockade in a Hypothetical Cohort in the USYiling Jiang, Lori D Bash, Leif Saager
Advances in Therapy|April 22, 2021
Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: UK and Ireland Results from the VISIONARY StudyEjaz Ansari, Jasna Pavicic-Astalos, Filis Ayan, et al.
Advances in Therapy|April 1, 2021
Humanistic and Economic Burden of Blindness Associated with Retinal Disorders in a Brazilian Sample: A Cross-Sectional StudyNilceia Lopes, Leticia Lucia Dos Santos Dias, Marcos Ávila, et al.
Advances in Therapy|April 21, 2021
CDC20 and PTTG1 are Important Biomarkers and Potential Therapeutic Targets for Metastatic Prostate CancerLiang Dai, Zi-Xuan Song, Da-Peng Wei, et al.
Pageof 452